AzTrials
AzTrials

Persistent Physical SymptomsNCT05287087

My Symptoms - Feasibility Study

A study testing My Symptoms 1 (MySt-1) and My Symptoms 2 (MySt-2) in people with Persistent Physical Symptoms, run by Aarhus University Hospital at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The proposed project 'My Symptoms' is part of a large research programme: eHealth and GP-assisted self-help interventions for persistent physical symptoms (eASY). See www.minesymptomer.dk. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Persistent Physical Symptoms
What is being tested?
My Symptoms 1 (MySt-1) and My Symptoms 2 (MySt-2)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteDenmark
Study dates
31 Mar 2022to 30 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Listed with participating practice
  • Giving informed consent to participation in the study
  • Consulting a GP or GP supervised staff
  • Multiple symptoms, i.e. 4 or more symptoms within the past 4 weeks, according to the Bodily Distress Syndrome checklist (a validated symptom checklist with 25 items)

Who cannot join

  • Not consulting for symptoms
  • Symptoms are due to acute disease
  • Symptoms must primarily be treated by medicine or surgery
  • Not eligible due to language or cognitive problems
  • Patient severely affected by other disease
  • Other, GP assessment/statement (e.g.: All symptoms are with recent onset and I see no need for intervention at present, I do not believe the patient will benefit the least bit from participation in the eHealth programme at this time)
Show all 10Show fewer
  • Patient declines to use the eHealth program despite GP recommendation
  • Patient has not accessed the programme within 2 weeks from referral from the GP
  • Criteria for stratification:
  • Long-term sick leave, i.e. more than 8 weeks, will be a criterion for stratification in order to enable analyses on the target group of patients with PPS without chronicity

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Aarhus University Hospital

    Aarhus, 8000

Other trials in Denmark

About this study

Official title: My Symptoms - Feasibility Study: Feasibility of Intervention and Evaluation of an eHealth and GP Assisted Programme for Persistent Symptoms in Primary Care for Persistent Symptoms in Primary Care

The proposed project 'My Symptoms' is part of a large research programme: eHealth and GP-assisted self-help interventions for persistent physical symptoms (eASY). See www.minesymptomer.dk.

The research programme is an ambitious and dedicated effort aiming at improvement of functioning and quality of life for individuals with persistent physical symptoms (PPS) and prevention of the development of chronic functional disorders and associated loss of working capacity and high use of health care. At present, access to specialized treatment of PPS is very limited and treatment capacity in general practice is restricted to brief consultations - often with poor opportunity to make a treatment plan for symptoms. In order to improve health care for patients with PPS, the investigators have developed a web-based selfhelp programme for symptoms. As part of the intervention, this programme is prescribed by the patient's general practitioner (GP). The investigators have applied a high degree of user involvement (GPs and patients) in the development process but there is a need to evaluate how the new treatment programme is in fact adopted and how it affects GPs in routine care and patients in daily life. With this study, the investigators wish to take the first step towards a comprehensive and rigorous evaluation. Results from this feasibility study will both qualify a subsequent randomised controlled trial (RCT) in a larger pilot study and provide information for a potential national dissemination.

Read the detailed description

Drawing on existing evidence about symptoms, functional disorders and eHealth interventions combined with user involvement, the investigators have developed a web-based self-help programme for PPS: "My Symptoms". The programme builds on the bio-psycho-socialexistential illness model and enhanced cognitive behavioural theory. Seven treatment modules focus on psychoeducation, lifestyle intervention, self-regulation and graded exercise delivered through text, videos, animations and audio files (see overview of content in table 1). Furthermore, it includes a 1-day course for GPs and a mandatory follow-up appointment between patient and GP at the programme closure. The training course for the GPs will focus on patient identification, positive reinforcement and familiarity with the content of the programme. The programme must be prescribed by GPs and is recommended to use for 6 weeks.

The objectives with the present feasibility study are: 1) to test and refine the GP training course, 2) to explore the planned logistics for patient recruitment, 3) to evaluate GP and patient questionnaires, and 4) to evaluate patients' use of the programme and 5) follow-up consultations with their GP.

With regard to 2-5, the following questions will be adressed and explored:

  1. Which modifications are needed to the predefined procedures for consecutive patient enrolment?
  2. What are the results of patient enrolment with respect to recruitment rates and patient characteristics? (Patients are asked and screened consecutively, but how many accept participation and fulfil inclusion criteria? What characterises enrolled patients compared to refusers?)
  3. To what extent do patients accept and engage with the baseline research questionnaires?
  4. When do included patients engage with the programme after enrolment (delay in time)?
  5. How much do included patients interact with the intervention, i.e. how many patients log into the program, which modules and pages are accessed, and how many tools are used?
  6. How many patients consult the GP for a follow-up consultation and when does this consultation take place?
  7. How many contacts do the patients have to participating practices during their use of the programme?

Alongside this part of the feasibility study, the investigators will conduct a separate in-depth qualitative study (field study observations and interviews) on GP and patient interactions with the intervention. A separate protocol has been developed for this part of the feasibility study.

Being tested
My Symptoms 1 (MySt-1), My Symptoms 2 (MySt-2)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • My Symptoms 1 (MySt-1)Behavioural

    The patients will get access to an eHealth programme consisting of:

    1. A questionnaire including the BDS checklist
    2. A brief introductory animation about how to understand symptoms in general
    3. Basic information on symptom in general and on six common symptoms: headache, fatigue, dizziness, pain, dyspepsia and abdominal unease.
    4. A brief animation about the interaction of body and mind.

    These four provisions are identical to the first part of the MySt-2.

  • My Symptoms 2 (MySt-2)Behavioural

    The patients will get access to an eHealth programme consisting of:

    1. A questionnaire including the BDS checklist
    2. A brief introductory animation about how to understand symptoms in general
    3. Basic information on symptom in general and on six common symptoms: headache, fatigue, dizziness, pain, dyspepsia and abdominal unease.
    4. A brief animation about the interaction of body and mind.
    5. Thorough symptom explanations
    6. Physical energy (focus on sleep, diet and activity)
    7. Values and choices (focus on meaning and existential issues)
    8. Emotional health (focus on emotion regulation)
    9. Mental energy (focus on stress regulation and thinking)

    After 4-6 weeks, the patient will see the GP for a follow-up consultation.

Study groups in NCT05287087
Study groupRoleWhat they receive
My Symptoms 1 (MySt-1)Active comparatorGPs will receive an introduction to the overall content of the eHealth programme MySt-1. The information will be given to participating GPs and their staff during a 1½-hour session in the practice. The research assistant will go through the logistics of the patient recruitment and evaluation step-by-step and GPs and relevant staff will subsequently have access to the programme. The patients will get access to a basic eHealth programme (My Symptoms 1). The programme is an internet-delivered self-help programme supporting patients' selfefficacy and behavioural changes. The programme is activated by the patient after prescription by the GP.
Receives: Behavioral: My Symptoms 1 (MySt-1)
My Symptoms 2 (MySt-2)ExperimentalGPs will attend a one-day training course of 7 hours including: in depth insight into the My Symptoms 2 eHealth programme, comprehensive understanding of PPS, training of communication skills and the use of contextual (non-specific/common psychological) factors. The training programme has been developed in cooperation with the national GP association offering CME (PLO-e). Lecturers and trainers will be GPs and psychologists from the research team. The patients will get access to an advanced eHealth programme (My Symptoms 2). The programme is an internet-delivered self-help programme supporting patients' selfefficacy and behavioural changes. The programme is activated by the patient after prescription by the GP.
Receives: Behavioral: My Symptoms 2 (MySt-2)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of patients in the target age group visiting the practice

    Measured: Recruitment (Week 1)

  2. Number of patients refusing participation

    Measured: Recruitment (Week 1)

  3. Number of patients fulfilling the inclusion criteria

    Measured: Recruitment (Week 1)

  4. Number of patients excluded by the GPs and reasons for this

    Measured: Recruitment and/or referral consultation (Week 1-3 expectedly)

  5. Number of patients not accepting the invitation for intervention despite consent to participate in the project (drop-outs)

    Measured: Invitation for referral consultation/at referral consultation (Week 1-3 expectedly)

  6. Number of patients who do not log into the programme within 2 weeks from referral or only log into the programme once (drop-outs)

    Measured: 2 weeks after referral consultation (Week 4-5 expectedly)

Secondary outcomes (17)
  1. Symptoms

    Bodily Distress Syndrome checklist

    Measured: Recruitment (screening), programme login (baseline), end of treatment

  2. Symptom intensity and interference

    Measured: Recruitment (screening), programme login (baseline), end of treatment

  3. Illness perception

    Illness Perception Questionnaire

    Measured: Recruitment (screening), programme login (baseline), end of treatment

  4. Anxiety and Depression

    Symptom Checklist (SCL)-13

    Measured: Recruitment (screening), programme login (baseline), end of treatment

  5. Health anxiety

    Whiteley-6R

    Measured: Recruitment (screening), programme login (baseline), end of treatment

  6. Global health

    One item from SF-36

    Measured: Recruitment (screening), programme login (baseline), end of treatment

  7. Evaluation of GP at referral consultation

    6 items

    Measured: Programme login (baseline)

  8. Program expectations

    2 items adapted from the Credibility Expectancy Questionnaire

    Measured: Programme login (baseline)

  9. Quality of life

    SF-36

    Measured: Programme login (baseline), end of treatment

  10. Quality of life

    EQ-5D-5L (EuroQol)

    Measured: Programme login (baseline), end of treatment

  11. Pain self-efficacy

    Pain Self-Efficacy Questionnaire

    Measured: Programme login (baseline), end of treatment

  12. Illness behavior

    The Behavioural Responses to Illness Questionnaire

    Measured: Programme login (baseline), end of treatment

  13. Productivity Costs

    Productivity Costs Questionnaire (IMTA)

    Measured: Programme login (baseline), end of treatment

  14. Health care utilization

    Medical Consumption Questionnaire (IMTA)

    Measured: Programme login (baseline), end of treatment

  15. Program evaluation

    13 items

    Measured: End of treatment

  16. Global impression of change

    1 item

    Measured: End of treatment

  17. Evaluation of GP at referral consultation

    2 items

    Measured: End of treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Mar 2022
  2. Study start31 Mar 2022
  3. Primary completion30 Sep 2022
  4. Study completion30 Jun 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05287087
Sponsor's protocol ID
1-10-72-372-21
Status last verified
Feb 2024
First submitted
10 Mar 2022
Last updated
23 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing My Symptoms 1 (MySt-1) and My Symptoms 2 (MySt-2) in people with Persistent Physical Symptoms, run by Aarhus University Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of patients in the target age group visiting the practice (time frame: Recruitment (Week 1)). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in